Mylan Launches Lithium Carbonate ER 450mg
Lithium Carbonate is indicated for the treatment of manic episodes of bipolar disorder and as maintenance treatment for individuals with a diagnosis of bipolar disorder. Lithium Carbonate is thought to exert its mood stabilizing effect by replacing sodium to inhibit voltage-sensitive sodium channels, causing stabilization of neuronal membranes.
Lithium Carbonate Extended-Release Tablets 450mg is being launched immediately.
For more information call (800) RX-MYLAN or visit www.mylan.com.